At DDOTS, our mission is to streamline the process of managing research. We support this by developing software systems that are intuitive and based on real-world experience. We strive to offer our systems at prices that are affordable so that as many research sites as possible will be able to implement them.
In 1995 DDOTS was engaged by a National Cancer Institute-sponsored clinical trials program to develop software for patient tracking and scheduling. What captured the interest of the DDOTS team was the fact that clinical trials were being conducted and tracked using 5×7 notecards or Excel spreadsheets at best. A vision for a comprehensive end-to-end clinical trials management solution was conceived. DDOTS was awarded a cooperative agreement from the National Institutes of Health that funded the development of CREDIT and IDEA and, as the saying goes, the rest is history.
Software as a Service (SaaS)
DDOTS offers four systems for managing clinical trials – and all as SaaS. CREDIT for clinical trials management, IRBANA for Institutional Review Board management, IDEA for investigational drug inventory management and BIOSPEC for biospecimen management. All four systems are superior stand-alone products, but also can communicate with each other to provide seamless solutions, hosted on dedicated web servers. Advantages include predictable costs with minimal upfront investment as well as automatic upgrades and security enhancements.
DDOTS provides these solutions as SaaS to alleviate the stress on in-house IT departments as they struggle to manage the complexities of multiple software system required by specialty program areas. It can be argued that CREDIT is the most affordable clinical trials managment system on the market. There is no hardware or software purchase required, only an annual license fee.
Key pricing elements.
Our pricing is easy to understand and very transparent. See pricing page for details. The number of affiliate sites, protocols and users covered by one license is unlimited. All software updates are free – and software is updated every 14 days.
New protocol builds can be downloaded from the DDOTS library for a mere $50 each, and all subsequent protocol updates/revision are free no matter how long the protocol is open or how many updates there are. Or, if you choose, you can build your own studies at no cost. The number of protocols that can be accommodated is unlimited. And – most critical – there is never a charge for technical support.
Unrivaled technical support
Email, telephone and web training support is offered during regular business hours M-F. We are resolute in our promise to provide a quick response when needed. Sometimes we know you need help before you do! We have an issue capture system that monitors the DDOTS systems nationwide. If an issue occurs, it is often corrected by the time a user reports it.
Installation and individualized roll-out plan
The DDOTS team works with you each step of the way to design and implement an installation plan that is customized to your institution, from research program staff to your IT department.
Data conversion from existing systems
One of the keys to a successful installation and transition to new software is accurate and complete data migration from an existing system. DDOTS has completed data conversions from just about all software programs available, from “home grown” systems to those currently on the market.
On-site training and individualized web-based training
Recognizing that it is never easy to adapt to new software regardless of “user-friendliness” of the program, DDOTS conducts on-site training for staff concurrent with the software installation to provide the support necessary for a successful transition. Web-based training is available on an ongoing basis as well as access to an ever-expanding help website.
Hosting services on dedicated servers
This requires no upfront capital investment and relieves institutions from the burden of managing, maintaining and supporting a custom system. Our servers pass annual HIPAA-compliance audits by an independent third party.